TraceLink NEXUS '11 Drives Outsourced Production, Serialization Discussions
16-Aug-2011Life Science Supply Chain and Production Leaders Discuss Key Outsourced Production, Serialization and Pharmaceutical Traceability Issues at TraceLink’s Supply Network NEXUS ’11
TraceLink, Inc., developer of the TraceLink Network, the world’s first industry-wide supply collaboration network, today announced Supply Network NEXUS '11. NEXUS ’11, being held on September 21st 2011 at the Hyatt Regency in New Brunswick NJ, brings together Life Science business and technical leaders to discuss serialization and traceability preparedness, outsourced production performance and strategic supply relationship development across the Life Sciences supply network.
NEXUS ’11 combines presentations, panel discussions, peer networking and hands-on demonstrations that provide business leaders with new ideas for improving performance, reducing risk and ensuring compliance in external supply operations and throughout product distribution. Sessions on the agenda include:
- The Value Chain Transformation in Life Sciences
- Global Serialization and Traceability – Regulations and GS1 Standards
- Track and Trace Pilot to Commercialization Timelines
- Track and Trace Architectures and Technologies (serialization, EPCIS, ePedigree)
- Track and Trace Requirements for the External Supply Network
- Improving KPIs in Outsourced Production – Research Study Results
- A Network Approach to Supply Collaboration and Visibility
- Improving Customer Service through Outsourced Manufacturing Collaboration
- Joint Value Creation across External Supply Relationships
- The Strategic Architecture to Ensure Supply, Capacity and Quality
“NEXUS ’11 brings together Life Science industry leaders to share specific knowledge and ideas on how to prepare their companies and their external supply network for today’s difficult global business environment,” said Shabbir Dahod, President and CEO of TraceLink. “As levels of outsourced production increase, track and trace regulatory deadlines from California, Turkey, Brazil and India approach and pressure to improve supply network KPIs grows, building a flexible supply plan is crucial. At NEXUS ’11, we focus on the strategic and operational issues executives need to consider when building a comprehensive strategy for optimizing outsourced production performance and ensuring product traceability.”
Attendees will hear thought-provoking ideas and strategies through presentations and panel discussions led by industry leaders from Top-5 pharmaceutical companies, leading contract manufacturing / packaging firms, noted industry consultants and standards organizations. Topics discussed will cover a range of top-of-mind issues for life science executives including the virtualization of drug manufacturing, clinical to commercial transitions, California 2015 readiness, counterfeit and diversion protection, and quality-by-design initiatives. Following the main sessions, business leaders will be able to experience a number of solution demonstrations including supply network collaboration and integration with SAP-based enterprises, consumer-level mobile authentication of pharmaceuticals and multi-enterprise quality review.
TraceLink’s Supply Network NEXUS ’11 is designed for leaders from pharmaceutical / biopharmaceutical companies, CMO / CPOs, pharmaceutical distributors and pharmacies. Registration is open to all with a particular focus on supply chain, operations, contract manufacturing, quality, customer service and IT teams.
To register for NEXUS '11, visit www.tracelink.com/supply-network-nexus-ll.
To learn more about TraceLink’s solutions for integrating the supply network, improving production visibility, enhancing pharmaceutical quality review coordination and ensuring pharmaceutical serialization and traceability compliance, visit www.tracelink.com.
About TraceLink:
TraceLink helps companies across the Life Sciences supply chain connect and collaborate to improve manufacturing and supply chain performance through the TraceLink Network. The TraceLink Network is a Cloud-based platform that prevents counterfeits, detects diversion, minimizes inventory, reduces cycle-time and ensures on-time delivery for all members of the supply chain by integrating its participants into a network of interoperable, collaborative business processes shared across companies. Pharmaceutical/biopharmaceutical companies and their supply chain partners quickly forge high-value partnerships by connecting with an “integrate-once, interoperate with everyone” transaction platform, an integrated set of shared business objects and a collaborative team workspace based on social networking principles that puts key and actionable supply network data into the hands of business owners.
TraceLink is funded by FirstMark Capital, a venture capital firm managing more than $2 billion in capital commitments. For more information on TraceLink and our solutions, visit www.tracelink.com.
Comment